Showing results (911-920 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|September 20, 2001
A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancerE E Vokes, G S Gordon, C M Rudin, et al.Investigational New Drugs|September 20, 2001
Therapeutic response to octreotide in patients with refractory CPT-11 induced diarrheaB Pro, R Lozano, J A AjaniInvestigational New Drugs|November 27, 2002
Licensure of gemtuzumab ozogamicin for the treatment of selected patients 60 years of age or older with acute myeloid leukemia in first relapseMark S Berger, Lance H Leopold, James A Dowell, et al.Investigational New Drugs|November 27, 2002
Irofulven, a novel inhibitor of DNA synthesis, in metastatic renal cell cancerRobert J Amato, Cherie Perez, Lance PagliaroInvestigational New Drugs|January 19, 2000
RAS inhibitors in hematologic cancers: biologic considerations and clinical applicationsD M Beaupre, R KurzrockInvestigational New Drugs|January 19, 2000
A new statistical method for dose-finding based on efficacy and toxicity in early phase clinical trialsP F Thall, E H Estey, H G SungInvestigational New Drugs|January 19, 2000
Phase II trial of menogaril in non-Hodgkin's lymphomas: a Southwest Oncology Group trialD F Moore, T D Brown, M LeBlanc, et al.Investigational New Drugs|August 25, 2000
Phase II study of intravenous Doxil in malignant pleural mesotheliomaY Oh, R Perez-Soler, F V Fossella, et al.Investigational New Drugs|August 25, 2000
Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomasT Chidiac, G T Budd, R Pelley, et al.Investigational New Drugs|June 17, 2000
UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell linesA Monks, E D Harris, A Vaigro-Wolff, et al.Pageof 372